The Biden administration’s plan to dispense COVID-19 booster shots to most Americans faced its first major hurdle Friday as a government advisory panel met to decide whether to endorse extra doses of the Pfizer vaccine.
FDA panel is first key test for Biden COVID-19 booster plan
